Cell proliferation, carcinogenesis and diverse mechanisms of telomerase regulation

Cellular and Molecular Life Sciences

Volumn 57, Issue 3, 2000, Pages 464-486

  Krupp, G ^a   Klapper, W ^a   Parwaresch, R ^a  

^a UNIVERSITY OF KIEL   (Germany)

Author keywords

Endometrium; Inhibitors; Molecular fossils; Polymerase; Rainbow trout

Indexed keywords

TELOMERASE;

CARCINOGENESIS; CELL PROLIFERATION; CHROMOSOME STRUCTURE; ENDOMETRIUM; ENZYME ACTIVITY; ENZYME ANALYSIS; FOSSIL; GENE REPLICATION; KNOCKOUT MOUSE; NONHUMAN; PROTEIN EXPRESSION; RAINBOW TROUT; REVIEW; TELOMERE;

MAMMALIA; ONCORHYNCHUS MYKISS; RNA VIRUSES; SALMONIDAE;

EID: 0033996493     PISSN: 1420682X     EISSN: None     Source Type: Journal    
DOI: 10.1007/PL00000708     Document Type: Review

References (248)

1. 1 Kornberg A. and Baker T. A. (1992) DNA Replication, Freeman, New York
2. 2 Weiner A. M. (1988) Eukaryotic nuclear telomeres: molecular fossils of the RNP world? Cell 52: 155-157
3. 3 Weiner A. M. and Maizels N. (1987) tRNA-like structures tag the 3′ ends of genomic RNA molecules for replication: implications for the origin of protein synthesis. Proc. Natl. Acad. Sci. USA 84: 7383-7387
4. 4 Singh R. N. and Dreher T. W. (1997) Turnip yellow mosaic virus RNA-dependent RNA polymerase: initiation of minus strand synthesis in vitro. Virology 233: 430-439
5. 5 Krupp G. (1989) Unusual promoter-independent transcription reactions with bacteriophage RNA polymerases. Nucleic Acids Res. 17: 3023-3036
6. 6 Kuhn A., Batsch I. and Grummt I. (1990) Specific interaction of the murine transcription termination factor TTF I with class-I RNA polymerases. Nature 344: 559-562
7. 7 Luo G. X. and Taylor J. (1990) Template switching by reverse transcriptase during DNA synthesis. J. Virol. 64: 4321-4328
8. 8 Diener T. O. (1989) Circular RNAs: relics of precellular evolution. Proc. Natl. Acad. Sci. USA 86: 9370-9374
9. 9 Olovnikov A. M. (1971) [Principle of marginotomy in template synthesis of polynucleotides]. Dokl. Acad. Nauk SSSR 201: 1496-1499
10. 10 Olovnikov A. M. (1973) A theory of marginotomy. The incomplete copying of template margin in enzymic synthesis of polynucleotides and biological significance of the phenomenon. J. Theor. Biol. 41: 181-190
11. 11 Watson J. D. (1972) Origin of concatemeric T7 DNA. Nature New Biol. 239: 197-201
12. 12 Blackburn E. H. and Gall J. G. (1978) A tandemly repeated sequence at the termini of the extrachromosomal ribosomal RNA genes in Tetrahymena. J. Mol. Biol. 120: 33-53
13. 13 Shampay J., Szostak J. W. and Blackburn E. H. (1984) DNA sequences of telomeres maintained in yeast. Nature 310: 154-160
14. 14 Meyne J., Ratliff R. L. and Moyzis R. K. (1989) Conservation of the human telomere sequence (TTAGGG)n among vertebrates. Proc. Natl. Acad. Sci. USA 86: 7049-7053
15. 15 Richards E. J. and Ausubel F. M. (1988) Isolation of a higher eukaryotic telomere from Arabidopsis thaliana. Cell 53: 127-136
16. 16 Okazaki S., Tsuchida K., Maekawa H., Ishikawa H. and Fujiwara H. (1993) Identification of a pentanucleotide telomeric sequence, (TTAGG)n, in the silkworm Bombyx mori and in other insects. Mol. Cell. Biol. 13: 1424-1432
17. 17 Klapper W., Kühne K., Singh K. K., Heidorn K., Parwaresch R. and Krupp G. (1998) Longevity of lobsters is linked to ubiquitous telomerase expression. FEBS Lett. 439: 143-146
18. 18 Klobutcher L. A., Swanton M. T., Donini P. and Prescott D. M. (1981) All gene-sized DNA molecules in four species of hypotrichs have the same terminal sequence and an unusual 3′-terminus. Proc. Natl. Acad. Sci. USA 78: 3015-3019
19. 19 Wellinger R. J., Ethier K., Labrecque P. and Zakian V. A. (1996) Evidence for a new step in telomere maintenaince. Cell 85: 423-433
20. 20 Makarov V. L., Hirose Y. and Langmore J. P. (1997) Long G tails at both ends of human chromosomes suggest a C strand degradation mechanism for telomere shortening. Cell 88: 657-666
21. 21 Henderson E., Hardin C. C., Walk S. K. and Blackburn E. H. (1987) Telomeric DNA oligonucleotides form novel intramolecular structures containing guanine:guanine base pairs. Cell 51: 899-908
22. 22 Rothstein R. J. (1983) One-step gene disruption in yeast. Methods Enzymol. 101: 202-211
23. 23 Muller H. J. (1938) The remaking of chromosomes. Collecting Net 13: 181-198
24. 24 Zahler A. M., Williamson J. R., Cech T. R. and Prescott D. M. (1991) Inhibition of telomerase by G-quartet DNA structures. Nature 350: 718-720
25. 25 LaBranche H., Dupuis S., Ben-David Y., Bani R. M., Wellinger R. J. and Chabot B. (1998) Telomere elongation by hnRNP A1 and a derivative that interacts with telomeric repeats and telomerase. Nature Genet. 19: 199-202
26. 26 Bianchi A., Smith S., Chong L., Elias P. and de Lange T. (1997) TRF1 is a dimer and bends telomeric DNA. EMBO J. 16: 1785-1794
27. 27 Broccoli D., Smogorzewska A., Chong L. and de Lange T. (1997) Human telomeres contain two distinct MYb-related proteins, TRF1 and TRF2. Nature Genet. 17: 231-235
28. 28 Smith S., Giriat I., Schmitt A. and de Lange T. (1998) Tankyrase, a poly(ADP-ribose) polymerase at human telomeres. Science 282: 1484-1487
29. 29 van Steensel B. and de Lange T. (1997) Control of telomere length by the human telomeric protein TRF1. Nature 385: 740-743
30. 30 van Steensel B., Smogorzewska A. and de Lange T. (1998) TRF2 protects human telomeres from end-to-end fusions. Cell 92: 401-413
31. 31 Bacchetti S. and Wynford-Thomas D. (guest editors) (1997) Special issue: telomeres and telomerase in cancer. Eur. J. Cancer 33: 703-800
32. 32 Olovnikov A. M. (guest editor) (1997) Special issue: telomere, telomerase, cancer and aging. Biochemistry 62: 1179-1338
33. 33 Kipling D. (1995) The Telomere. Oxford University Press, Oxford
34. 34 Blackburn E. H. and Greider C. W. (1995) Telomeres. CSHL Press, Cold Spring Harbor, NY
35. 35 Griffith J. D., Comeau L., Rosenfield S., Stansel R. M., Bianchi A., Moss H. et al. (1999) Mammalian telomeres end in a large duplex loop. Cell 97: 503-514
36. 36 Biessmann H., Carter S. B. and Mason J. M. (1990) Chromosome ends in Drosophila without telomeric DNA sequences. Proc. Natl. Acad. Sci. USA 87: 1758-1761
37. 37 Zhang Y. J., Kamnert I., Lopez C. C., Cohn M. and Edstrom J. E. (1994) A family of complex tandem DNA repeats in the telomeres of Chironomus pallidivittatus. Mol. Cell. Biol. 14: 8028-8036
38. 38 Pardue M. L. and DeBaryshe P. G. (1999) Telomeres and telomerase: more than the end of the line. Chromosoma 108: 73-82
39. 39 Oka Y., Shiota S., Nakai S., Nishida Y. and Okubo S. (1980) Inverted terminal repeat sequence in the macronuclear DNA of Stylonichia pustulata. Gene 10: 301-306
40. 40 Wellinger R. J., Wolf A. J. and Zakian V. A. (1993) Saccharomyces telomeres acquire single-strand TG1-3 tails late in S phase. Cell 72: 51-60
41. 41 Greider C. W. and Blackburn E. H. (1985) Identification of a specific telomere terminal transferase activity in Tetrahymena extracts. Cell 43: 405-413
42. 42 Greider C. W. and Blackburn E. H. (1989) A telomeric sequence in the RNA of Tetrahymena telomerase required for telomere repeat synthesis. Nature 337: 331-337
43. 43 Feng J., Funk W. D., Wang S. S., Weinrich S. L., Avilion A. A., Chiu C. P. et al. (1995) The RNA component of human telomerase. Science 269: 1236-1241
44. 44 Collins K., Kobayashi R. and Greider C. W. (1995) Purification of Tetrahymena telomerase and cloning of genes encoding the two protein components of the enzyme. Cell 81: 677-686
45. 45 Nakayama J., Saito M., Nakamura H. and Ishikawa F. (1997) TLP1: a gene encoding a protein component of mammalian telomerase is a novel member of WD reapeats family. Cell 88: 875-884
46. 46 Harrington L. A., McPhail T., Mar V., Zhou W., Oulton R., Amgen et al. (1997) A mammalian telomerase associated protein. Science 275: 973-977
47. 47 Lingner J. and Cech T. R. (1996) Purification of telomerase from Euplotes aediculatus: requirement of a primer 3′ overhang. Proc. Natl. Acad. Sci. USA 93: 10712-10717
48. 48 Lingner J., Hughes T. R., Shevchenko A., Mann M., Lundblad V. and Cech T. R. (1997) Reverse transcriptase motifs in the catalytic subunit of telomerase. Science 276: 561-567
49. 49 Harrington L., Zhou W., McPhail T., Oulton R., Yeung D. S. K., Mar V. et al. (1997) Human telomerase contains evolutionary conserved catalytic and structural subunits. Genes Dev. 11: 3109-3115
50. 50 Meyerson M., Counter C. M., Eaton E. N., Ellisen L. W., Steiner P., Caddle S. D. et al. (1997) hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization. Cell 90: 785-795
51. 51 Nakamura T. M., Morin G. B., Chapman K. B., Weinrich S. L., Andrews W. H., Lingner J. et al. (1997) Telomerase catalytic subunit homologs from fission yeast and human. Science 277: 955-959
52. 52 Kilian A., Bowtell D. D., Abud H. E., Hime G. R., Venter D. J., Keese P. K. et al. (1997) Isolation of a candidate human telomerase catalytic subunit gene, which reveals complex splicing patterns in different cell types. Hum. Mol. Genet. 6: 2011-2019
53. 53 Collins K. and Gandhi L. (1998) The reverse transcriptase component of the Tetrahymena telomerase ribonucleoprotein complex. Proc. Natl. Acad. Sci. USA 95: 8485-8490
54. 54 Weinrich S. L., Pruzan R., Ma L., Ouellette M., Tesmer V. M., Holt S. E. et al. (1997) Reconstitution of human telomerase with the template RNA component hTR and the catalytic subunit hTRT. Nature Genet. 17: 498-502
55. 55 Beattie T. L., Zhou W., Robinson M. O. and Harrington E. (1998) Reconstitution of human telomerase activity in vitro. Curr. Biol. 8: 177-180
56. 56 Morin G. B. (1989) The human telomere terminal transferase enzyme is a ribonucleoprotein that synthesizes TTAGGG repeats. Cell 59: 521-529
57. 57 Kim N. W., Piatyszek M. A., Prowse K. R., Harley C. B., West M. D., Ho P. L. C. et al. (1994) Specific association of human telomerase activity with immortal cells and cancer. Science 266: 2011-2015
58. 58 Morin G. B. (1991) Recognition of a chromosome truncation site associated with alpha-thalassaemia by human telomerase. Nature 353: 454-456
59. 59 Hastie N. D., Dempster M., Dunlop M. G., Thompson A. M., Green D. K. and Allshire R. C. (1990) Telomere reduction in human colorectal carcinoma and with ageing. Nature 346: 866-868
60. 60 Harley C. B., Futcher A. B. and Greider C. W. (1990) Telomeres shorten during ageing of human fibroblasts. Nature 345: 458-460
61. 61 Cooke H. J. and Smith B. A. (1986) Variability at the telomeres of the human X/Y pseudoautosomal region. Cold Spring Harbor Symp. Quant. Biol. 51: 213-219
62. 62 Allshire R. C., Gosden J. R., Cross S. H., Cranston G., Rout D., Sugawara N. et al. (1988) Telomeric repeat from T. thermophila cross hybridizes with human telomeres. Nature 332: 656-659
63. 63 de Lange T., Shiue L., Myers R. M., Cox D. R., Naylor S. L., Killery A. M. et al. (1990) Structure and variability of human chromosome ends. Mol. Cell. Biol. 10: 518-527
64. 64 Greider C. W. (1990) Telomeres, telomerase and senescence. Bioessays 12: 363-369
65. 65 Harley C. B. (1991) Telomere loss: mitotic clock or genetic time bomb? Mutation Res. 256: 271-282
66. 66 Hayflick L. and Moorhead P. S. (1961) The serial cultivation of human diploid cell strains. Exp. Cell. Res. 25: 585-621
67. 67 Counter C. M., Avilion A. A., LeFeuvre C. E., Stewart N. G., Greider C. W., Harley C. B. et al. (1992) Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. EMBO J. 11: 1921-1929
68. 68 Counter C. M., Hirte H. W., Bacchetti S. and Harley C. B. (1994) Telomerase activity in human ovarian carcinoma. Proc. Natl. Acad. Sci. USA 91: 2900-2904
69. 69 Sharma M. C., Sokoloski J. A., Perez J. R., Maltese J. Y., Sartorelli A. C., Stein C. A. et al. (1995) Differentiation of immortal cells inhibits telomerase acticity. Proc. Natl. Acad. Sci. USA 92: 12343-12346
70. 70 Holt S. E., Wright W. E. and Shay J. W. (1996) Regulation of telomerase activity in immortal cell lines. Mol. Cell. Biol. 16: 2932-2939
71. 71 Savoysky E., Yoshida K., Ohtomo T., Yamaguchi Y., Akamatsu K., Yamazaki T. et al. (1996) Down-regulation of telomerase activity is an early event in the differentiation of HL60 cells. Biochem. Biophys. Res. Commun. 226: 329-334
72. 72 Shay J. W. and Wright W. E. (1996) The reactivation of telomerase activity in cancer progression. Trends Genet. 12: 129-131
73. 73 Shay J. W., Werbin H. and Wright W. E. (1996) Telomeres and telomerase in human leukemias. Leukemia 10: 1255-1261
74. 74 Greaves M. (1996) Is telomerase activity in cancer due to selection of stem cells and differentiation arrest? Trends Genet. 12: 127-128
75. 75 Broccoli D., Young J. W. and de Lange T. (1995) Telomerase activity in normal and malignant hematopoietic cells. Proc. Natl. Acad. Sci. USA 92: 9082-9086
76. 76 Counter C. M., Gupta J., Harley C. B., Leber B. and Bacchetti S. (1995) Telomerase activity in normal leukocytes and in hematologic malignancies. Blood 85: 2315-2320
77. 77 Hiyama K., Hirai Y., Kyoizumi S., Akiyama M., Hiyama E., Piatyszek M. A. et al. (1995) Activation of telomerase in human lymphocytes and hematopoietic progenitor cells. J. Immunol. 155: 3711-3715
78. 78 Bodnar A. G., Kim N. W., Effros R. B. and Chiu C. P. (1996) Mechanism of telomerase induction during T cell activation. Exp. Cell Res. 228: 58-64
79. 79 Igarashi H. and Sakaguchi N. (1996) Telomerase activity is induced by the stimulation to antigen receptor in human peripheral lymphocytes. Biochem. Biophys. Res. Commun. 219: 649-655
80. 80 Igarashi H. and Sakaguchi N. (1997) Telomerase activity is induced in human peripheral B lymphocytes by the stimulation to antigen receptor. Blood 89: 1299-1307
81. 81 Weng N. P., Levine B. L., June C. H. and Hodes R. J. (1996) Regulated expression of telomerase activity in human T lymphocyte development and activation. J. Exper. Med. 183: 2471-2479
82. 82 Taylor R. S., Ramirez R. D., Ogoshi M., Chaffins M., Piatyszek M. A. and Shay J. W. (1996) Detection of telomerase activity in malignant and nonmalignant skin conditions. J. Invest. Dermatol. 106: 759-765
83. 83 Härle-Bachor C. and Boukamp P. (1996) Telomerase activity in the regenerative basal layer of the epidermis in human skin and in immortal and carcinoma-derived skin keratinocytes. Proc. Natl. Acad. Sci. USA 93: 6476-6481
84. 84 Hiyama E., Hiyama K., Tatsumoto N., Shay J. W. and Yokoyama T. (1996) Telomerase activity in human intestine. Int. J. Oncol. 9: 453-458
85. 85 Ramirez R. D., Wright W. E., Shay J. W. and Taylor R. S. (1997) Telomerase activity concentrates in the mitotically active segments of human hair follicles. J. Invest. Dermatol. 108: 113-117
86. 86 Brien T. P., Kallakury B. V., Lowry C. V., Ambros R. A., Muraca P. J., Malfetano J. H. et al. (1997) Telomerase activity in benign endometrium and endometrial carcinoma. Cancer Res. 57: 2760-2764
87. 87 Kyo S., Takakura M., Kohama T. and Inoue M. (1997) Telomerase activity in human endometrium. Cancer Res. 57: 610-614
88. 88 Saito T., Schneider A., Martel N., Mizumoto H, Bulgay-Moerschel M., Kudo R. et al. (1997) Proliferation-associated regulation of telomerase activity in human endometrium and its potential implication in early cancer diagnosis. Biochem. Biophys. Res. Commun. 231: 610-614
89. 89 Shroyer K. R., Stephens J. K., Silverberg S. G., Markham N., Shroyer A. L., Wilson M. L. et al. (1997) Telomerase expression in normal endometrium, endometrial hyperplasia, and endometrial adenocarcinoma. Int. J. Gynecol. Pathol. 16: 225-232
90. 90 Bonatz G., Klapper W., Barthe A., Heidorn K., Jonat W., Krupp G. et al. (1998) Analysis of telomerase expression and proliferative activity in the different layers of cyclic endometrium. Biochem. Biophys. Res. Commun. 253: 214-221
91. 91 Klapper W., Singh K. K., Heidorn K., Parwaresch R. and Krupp G. (1998) Regulation of telomerase activity in quiescent immortalized human cells. Biochim. Biophys. Acta 1442: 120-126
92. 92 Gerdes J., Dallenbach F., Lennert K., Lemke H. and Stein H. (1984) Growth fractions in malignant non-Hodgkin's lymphomas (NHL) as determined in situ with the monoclonal antibody Ki-67. Hematol. Oncol. 2: 365-371
93. 93 Greider C. W. (1998) Telomerase activity, cell proliferation and cancer. Proc. Natl. Acad. Sci. USA 95: 90-92
94. 94 Kreipe H., Wacker H. H., Heidebrecht H. J., Haas K., Hauberg M., Tiemann M. et al. (1993) Determination of the growth fraction in non-Hodgkin's lymphomas by monoclonal antibody Ki-S5 directed against a formalin-resistant epitope of the Ki-67 antigen. Am. J. Pathol. 142: 1689-1694
95. 95 Holt S. E., Aisner D. L., Shay J. W. and Wright W. E. (1997) Lack of cell cycle regulation of telomerase activity in human cells. Proc. Natl. Acad. Sci. USA 94: 10687-10692
96. 96 Belair C. D., Yeager T. R., Lopez P. M. and Reznikoff C. A. (1997) Telomerase activity: a biomarker of cell proliferation, not malignant transformation. Proc. Natl. Acad. Sci. USA 94: 13677-13682
97. 97 Wright W. E., Piatyszek M. A., Rainey W. E., Byrd W. and Shay J. W. (1996) Telomerase activity in human germline and embryonic tissues and cells. Dev. Genet. 18: 173-179
98. 98 Tahara H., Nakanishi T., Kitamoto M., Nakashio R., Shay J. W., Tahara E. et al. (1995) Telomerase activity in human liver tissues: comparison between chronic liver disease and hepatocellular carcinomas. Cancer Res. 55: 2734-2736
99. 99 Kojima H., Yokosuka O., Imazeki F., Saisho H. and Omata M. (1997) Telomerase activity and telomere length in hepatocellular carcinoma and chronic liver disease. Gastroenterology 112: 493-500
100. 100 Prowse K. R., Avilion A. A. and Greider C. W. (1993) Identification of a nonprocessive telomerase activity from mouse cells. Proc. Natl. Acad. Sci. USA 90: 1493-1497
101. 101 Prowse K. R. and Greider C. W. (1995) Developmental and tissue-specific regulation of mouse telomerase and telomere length. Proc. Natl. Acad. Sci. USA 92: 4818-4822
102. 102 Blasco M. A., Funk W., Villeponteau B. and Greider C. W. (1995) Functional characterization and developmental regulation of mouse telomerase RNA. Science 269: 1267-1270
103. 103 Fitzgerald M. S., McKnight T. D. and Shippen D. E. (1996) Characterization and developmental patterns of telomerase expression in plants. Proc. Natl. Acad. Sci. USA 93: 14422-14427
104. 104 Heller K., Kilian A., Piatyszek M. A. and Kleinhofs A. (1996) Telomerase activity in plant extracts. Mol. Gen. Genet. 252: 342-345
105. 105 Krupp G., Kühne K., Tamm S., Klapper W., Heidorn K., Rott A. et al. (1997) Molecular basis of artifacts in the detection of telomerase activity and a modified primer for a more robust 'TRAP' assay. Nucleic Acids Res. 25: 919-921
106. 106 Klapper W., Heidorn K., Kühne K., Parwaresch R. and Krupp G. (1998) Telomerase activity in 'immortal' fish. FEBS Lett. 434: 409-412
107. 107 Ortego L. S., Hawkins W. E., Walker W. W., Krol R. M. and Benson W. H. (1994) Detection of proliferating cell nuclear antigen in tissues of three small fish species. Biotechnic Histochem. 69: 317-323
108. 108 Hiyama E., Hiyama K., Yokoyama T., Matsuura Y., Piatyszek M. A. and Shay J. W. (1995) Correlating telomerase activity levels with human neuroblastoma outcomes. Nature Med. 1: 249-255
109. 109 Langford L. A., Piatyszek M. A., Xu R., Schold S. C. Jr and Shay J. W. (1995) Telomerase activity in human brain tumors. Lancet 346: 1267-1268
110. 110 Langford L. A., Piatyszek M. A., Xu R., Schold S. C. Jr, Wright W. E. and Shay J. W. (1997) Telomerase activity in ordinary meningiomas predicts poor outcome. Hum. Pathol. 28: 416-420
111. 111 Nakatani K., Yoshimi N., Mori H., Yoshimura S., Sakai H., Shinoda J. et al. (1997) The significant role of telomerase activity in human brain tumors. Cancer 80: 471-476
112. 112 Hiyama E., Hiyama K., Ohtsu K., Yamaoka H., Ichikawa T., Shay J. W. et al. (1997) Telomerase activity in neuroblastoma: is it a prognostic indicator of clinical behaviour? Eur. J. Cancer 33: 1932-1936
113. 113 Zhang W., Piatyszek M. A., Kobayashi T., Estey E., Andreeff M., Deisseroth A. B. et al. (1996) Telomerase activity in human acute myelogenous leukemia: inhibition of telomerase activity by differentiation-inducing agents. Clin. Cancer Res. 2: 799-803
114. 114 Oyashiki J. H., Oyashiki K. and Iwama H. (1997) Clinical implications of telomerase activity levels in acute leukemia. Clin. Cancer Res. 3: 619-625
115. 115 Hiyama E., Gollahon L., Kataoka T., Kuroi K., Yokoyama T., Gazdar A. F. et al. (1996) Telomerase activity in human breast tumors. J. Natl. Cancer Inst. 88: 116-122
116. 116 Clark G. M, Osborne C. K., Levitt D., Wu F. and Kim N. W. (1997) Telomerase activity and survival of patients with node-positive breast cancer. J. Natl. Cancer Inst. 89: 1874-1881
117. 117 Hoos A., Hepp H. H., Kaul S., Ahlert T., Bastert G. and Wallwiener D. (1998) Telomerase activity correlates with tumor aggressiveness and reflects therapy effect in breast cancer. Int. J. Cancer 79: 8-12
118. 118 Glaessl A., Bosserhoff A. K., Buettner R., Hohenleutner U., Landthaler M. and Stolz W. (1999) Increase in telomerase activity during progression of melanocytic cells from melanocytic naevi to malignant melanomas. Arch. Dermatol. Res. 291: 81-87
119. 119 Rudolph P., Schubert C., Tamm S., Heidorn K., Hauschild A., Michalska I. et al. (2000) Telomerase activity in melanocytic lesions a potential marker of tumor biology. Am. J. Pathol., in press
120. 120 Tahara H., Kuniyasu H., Yokozaki H., Yasui W., Shay J. W., Ide T. et al. (1995) Telomerase activity in preneoplastic and neoplastic gastric and colorectal lesions. Clin. Cancer Res. 1: 1245-1251
121. 121 Hiyama E., Yokoyama T., Tatsumoto N., Hiyama K., Imamura Y., Murakami Y. et al. (1995) Telomerase activity in gastric cancer. Cancer Res. 55: 3258-3262
122. 122 Ahn M. J., Noh Y. H., Lee Y. S., Lee J. H., Chung T. J., Kim I. S. et al. (1997) Telomerase activity and its clinicopathological significance in gastric cancer. Eur. J. Cancer 33: 1309-1313
123. 123 Urquidi V., Tarin D. and Goodison S. (1998) Telomerase in cancer: clinical applications. Ann. Med. 30: 419-430
124. 124 Shay J. W. (1998) Telomerase in cancer: diagnostic, prognostic and therapeutic implications. Cancer J. Sci. Am. 4(Suppl. 1): S26-S34
125. 125 McKenzie K. E., Umbricht C. B. and Sukumar S. (1999) Applications of telomerase research in the fight against cancer. Mol. Med. Today 5: 114-122
126. 126 Heidebrecht H. J., Buck F., Steinmann J., Sprenger R., Wacker H. H. and Parwaresch R. (1997) p100: a novel proliferation-associated nuclear protein specifically restricted to cell cycle phases S, G2 and M. Blood 90: 226-233
127. 127 Reference removed in proof
128. 128 Iwao T., Hiyama E., Yokoyama T., Tsuchida A., Hiyama K., Murakami Y. et al. (1997) Telomerase activity for the preoperative diagnosis of pancreatic cancer. J. Natl. Cancer Inst. 89: 1621-1623
129. 129 Duggan B. D., Wan M., Yu M. C., Roman L. D., Muderspach L. I., Delgadillo E. et al. (1998) Detection of ovarian cancer cells: comparison of a telomerase assay and cytologic examination. J. Natl. Cancer Inst. 90: 238-242
130. 130 Sawant S. G., Gregoire V., Dhar S., Umbricht C. B., Cvilic S., Sukumar S. et al. (1999) Telomerase activity as a measure for monitoring radiocurability of tumor cells. FASEB J. 13: 1047-1054
131. 131 Ohyashiki K., Yahata N., Iwama H., Aizawa T. and Miki M. (1998) [Telomerase activity and determination of cancer in urological neoplasias using exfoliated urinary cells: in situ TRAP assay and its application]. Nippon Rinsho 56: 1299-1303
132. 132 Wright W. E., Shay J. W. and Piatyszek M. A. (1995) Modifications of a telomeric repeat amplification protocol (TRAP) result in increased reliability, linearity and sensitivity. Nucleic Acids Res. 23: 3794-3795
133. 133 Kim N. W. and Wu F. (1997) Advances in quantification and characterization of telomerase activity by the telomeric repeat amplification protocol (TRAP). Nucleic Acids Res. 25: 2595-2597
134. 134 Yan P., Bosman F. T. and Benhattar J. (1998) Tissue quality is an important determinant of telomerase activity as measured by TRAP assay. Biotechniques 25: 660-662
135. 135 Norrback K. F., Enblad G., Erlanson M., Sundstrom C. and Roos G. (1998) Telomerase activity in Hodgkin's disease. Blood 92: 567-573
136. 136 Klapper W., Hanne A., Heidorn K., Parwaresch R. and Krupp G. (1999) TRAP assay technical aspects: detect and inhibit RNases in lysates. Cold Spring Harbor Meeting on Telomeres and Telomerase, p. 72
137. 137 Ohyashiki K., Ohyashiki J. H., Nishimaki J., Toyama K., Ebihara Y., Kato H. et al. (1997) Cytological detection of telomerase activity using an in situ telomeric repeat amplification protocol assay. Cancer Res. 57: 2100-2103
138. 138 Ulaner G. A., Hu J. F., Vu T. H., Giudice L. C. and Hoffman A. R. (1998) Telomerase activity in human development is regulated by human telomerase reverse transcriptase (hTERT) transcription and by alternate splicing of hTERT transcripts. Cancer Res. 58: 4168-4172
139. 139 Liu K., Schoonmaker M. M., Levine B. L., June C. H., Hodes R. J. and Weng N. (1999) Constitutive and regulated expression of telomerase reverse transcriptase (hTERT) in human lymphocytes. Proc. Natl. Acad. Sci. USA 96: 5147-5152
140. 140 Ramakrishnan S., Eppenberger U., Mueller H., Shinkai Y. and Narayanan R. (1998) Expression profile of the putative catalytic subunit of the telomerase gene. Cancer Res. 58: 622-625
141. 141 Li H., Zhao L. L., Funder J. W. and Liu J. P. (1997) Protein phosphatase 2A inhibits nuclear telomerase activity in human breast cancer cells. J. Biol. Chem. 272: 16729-16732
142. 142 Li H., Zhao L., Yang Z., Funder J. W. and Liu J. P. (1998) Telomerase is controlled by protein kinase Calpha in human breast cancer cells. J. Biol. Chem. 273: 33436-33442
143. 143 Kang S. S., Kwon T., Kwon D. Y. and Do S. I. (1999) Akt protein kinase enhances human telomerase activity through phosphorylation of telomerase reverse transcriptase subunit. J. Biol. Chem. 274: 13085-13090
144. 144 Tahara H., Yasui W., Tahara E., Fujimoto J., Ito K., Tamai K. et al. (1999) Immuno-histochemical detection of human telomerase catalytic component, hTERT, in human colorectal tumor and non-tumor tissue sections. Oncogene 18: 1561-1567
145. 145 Bacchetti S. (1996) Telomere maintenance in tumour cells. Cancer Surv. 28: 197-216
146. 146 Lundblad V. and Blackburn E. H. (1993) An alternative pathway for yeast telomere maintenance rescues est 1-senescence. Cell 73: 347-360
147. 147 Murnane J. P., Sabatier L., Marder B. A. and Morgan W. F. (1994) Telomere dynamics in an immortal human cell line. EMBO J. 13: 4953-4962
148. 148 Bryan T. M., Englezou A., Gupta J., Bacchetti S. and Reddel R. R. (1995) Telomere elongation in immortal cells without detectable telomerase activity. EMBO J. 14: 4240-4248
149. 149 Bryan T. M. and Reddel R. R. (1997) Telomere dynamics and telomerase activity in in vitro immortalised human cells. Eur. J. Cancer 33: 767-773
150. 150 Norton J. C., Piatyszek M. A., Wright W. E., Shay J. W. and Corey D. R. (1996) Inhibition of human telomerase by peptide nucleic acids. Nature Biotech. 14: 615-619
151. 151 Blasco M. A., Lee H. W., Hande M. P., Samper E., Lansdorp P. M., DePinho R. A. et al. (1997) Telomere shortening and tumor formation by mouse cells lacking telomerase RNA. Cell 91: 25-34
152. 152 Lee H. W., Blasco M. A., Gottlieb G. J., Horner J. W. II and DePinho R. A. (1998) Essential role of mouse telomerase in highly proliferative organs. Nature 392: 569-574
153. 153 Strahl C. and Blackburn E. H. (1996) Effects of reverse transcriptase inhibitors on telomere length and telomerase activity in two immortalized human cell lines. Mol. Cell. Biol. 16: 53-65
154. 154 Yegorov Y. E., Chernov D. N., Akimov S. S., Akhmalisheva A. K., Smirnova Y. B., Shinkarev D. B. et al. (1997) Blockade of telomerase function by nucleoside analogs. Biochemistry 62: 1296-1305
155. 155 Pai R. B., Pai B., Kukhanova M, Dutschmann G. E., Guo X. and Cheng Y. C. (1998) Telomerase from human leukemia cells: properties and its interaction with deoxynucleotide analogues. Cancer Res. 58: 1909-1913
156. 156 Melana S. M., Holland J. F. and Pogo B. G. (1998) Inhibition of cell growth and telomerase activity of breast cancer cells in vitro by 3′-azido-3′-deoxythymidine. Clin. Cancer Res. 4: 693-696
157. 157 Ishibashi T. and Lippard S. J. (1998) Telomere loss in cells treated with cisplatin. Proc. Natl. Acad. Sci. USA 95: 4219-4223
158. 158 Naasani I., Seimiya H. and Tsuruo T. (1998) Telomerase inhibition, telomere shortening and senescence of cancer cells by tea catechins. Biochem. Biophys. Res. Commun. 249: 391-396
159. 159 Nakane H. and Ono K. (1990) Differential inhibitory effects of some catechin derivatives on the activities of human immunodeficiency virus reverse transcriptase and cellular deoxyribonucleic and ribonucleic acid polymerases. Biochemistry 29: 2841-2845
160. 160 Pitts A. E. and Corey D. R. (1998) Inhibition of human telomerase by 2′-O-methyl-RNA. Proc. Natl. Acad. Sci. USA 95: 11549-11554
161. 161 Mata J. E., Joshi S. S., Palen B., Pirruccello S. J., Jackson J. D., Elias N. et al. (1997) A hexameric phosphorothioate oligonucleotide telomerase inhibitor arrests growth of Burkitt's lymphoma cells in vitro and in vivo. Toxicol. Appl. Pharmacol. 144: 189-197
162. 162 Matthes E. and Lehmann C. (1999) Telomerase protein rather than its RNA is the target of phosphorothioate-modified oligonucleotides. Nucleic Acids Res. 27: 1152-1158
163. 163 Wan M. S. K., Fell P. L. and Akhtar S. (1998) Synthetic 2′-O-methyl-modified hammerhead ribozymes targeted to the RNA component of telomerase as sequence-specific inhibitors of telomerase activity. Antisense Nucleic Acid Drug Dev. 8: 309-317
164. 164 Yokoyama Y., Takahashi Y., Shinohara A., Lian Z., Wan X., Niwa K. et al. (1998) Attenuation of telomerase activity by a hammerhead ribozyme targeting the template region of telomerase RNA in endometrial carcinoma cells. Cancer Res. 58: 5406-5410
165. 165 Hamilton S. E., Pitts A. E., Katipally R. R., Jia X., Rutter J. P., Davies B. A. et al. (1997) Identification of determinants for inhibitor binding within the RNA active site of human telomerase using PNA scanning. Biochemistry 36: 11873-11880
166. 166 Hamilton S. E., Simmons C. G., Kathiriya I. S. and Corey D. R. (1999) Cellular delivery of peptide nucleic acids and inhibition of human telomerase. Chem. Biol. 6: 343-351
167. 167 Fletcher T. M., Salazar M. and Chen S. F. (1996) Human telomerase inhibition by 7-deaza-2′-deoxypurine nucleoside triphosphates. Biochemistry 35: 15611-15617
168. 168 Pandit B. and Bhattacharyya N. P. (1998) Detection of telomerase activity in Chinese hamster V79 cells and its inhibition by 7-deaza-deoxy guanosine triphosphate and (TTAGGG)4 in vitro. Biochem. Biophys. Res. Commun. 251: 620-624
169. 169 Togashi K., Kakeya H., Morishita M., Song Y. X. and Osada H. (1998) Inhibition of human telomerase activity by alterperylenol. Oncol. Res. 10: 449-453
170. 170 Fedoroff O. Y., Salazar M., Han H., Chemeris V. V., Kerwin S. M. and Hurley L. H. (1998) NMR-Based model of a telomerase inhibiting compound bound to G-quadruplex DNA. Biochemistry 37: 12367-12374
171. 171 Perry P. J., Reszka A. P., Wood A. A., Read M. A., Gowan S. M., Dosanjh H. S. et al. (1998) Human telomerase inhibition by regioisomeric disubstituted amidoanthracene-9,10-diones. J. Med. Chem. 41: 4873-4884
172. 172 Fu W., Begley J. G., Killen M. W. and Mattson M. P. (1999) Anti-apoptotic role of telomerase in pheochromocytoma cells. J. Biol. Chem. 274: 7264-7271
173. 173 Sogawa K., Sumida T., Hamakawa H., Yamada T., Matsumoto K., Matsuda M. et al. (1998) Telomerase inhibitors. United States Patent 5,703,116
174. 174 Sogawa K., Sumida T., Hamakawa H., Yamada T., Matsumoto K., Matsuda M. et al. (1998) Inhibitory effect of a marine microalgal polysaccharide on the telomerase activity in K562 cells. Res. Commun. Mol. Pathol. Pharmacol. 99: 259-265
175. 175 Hogan J. C. Jr (1996) Directed combinatorial chemistry. Nature 384: 17-19
176. 176 Runge K. W. and Zakian V. A. (1989) Introduction of extra telomeric DNA sequences into Saccharomyces cerevisiae results in telomere elongation. Mol. Cell. Biol. 9: 1488-1497
177. 177 Wright W. E., Brasiskyte D., Piatyszek M. A. and Shay J. W. (1996) Experimental elongation of telomeres extends the lifespan of immortal × normal cell hybrids. EMBO J. 15: 1734-1741
178. 178 Bodnar A. G., Ouellette M., Frolkis M., Holt S. E., Chiu C. P., Morin G. B. et al. (1998) Extension of life-span by introduction of telomerase into normal human cells. Science 279: 349-352
179. 179 Morales C. P., Holt S. E., Ouellette M., Kaur K. J., Yan Y., Wilson K. S. et al. (1999) Absence of cancer-associated changes in human fibroblasts immortalized with telomerase. Nature Genet. 21: 115-118
180. 180 Jiang X. R., Jimenez G., Chang E., Frolkis M., Kusler B., Sage M. et al. (1999) Telomerase expression in human somatic cells does not induce changes associated with a transformed phenotype. Nature Genet. 21: 111-114
181. 181 Rubin H. (1998) Telomerase and cellular lifespan: ending the debate? Nature Biotech. 16: 396-397
182. 182 Kiyono T., Foster S. A., Kooter J. M., McDougall J. K., Galloway D. A. and Klingelhutz A. J. (1998) Both Rb/ p16(INK4a) inactivation and telomerase activity are required to immortalize human epithelial cells. Nature 396: 84-88
183. 183 Wei S. and Sedivy J. M. (1999) Expression of catalytically active telomerase does not prevent premature senescence caused by overexpression of oncogenic Ha-Ras in normal human fibroblasts. Cancer Res. 59: 1539-1543
184. 184 Ouellette M. M., Aisner D. L., Savre-Train I., Wright W. E. and Shay J. W. (1999) Telomerase activity does not always imply telomere maintenance. Biochem. Biophys. Res. Commun. 254: 795-803
185. 185 Shiels P. G., Kind A. J., Campbell K. H., Waddington D., Wilmut I., Colman A. et al. (1999) Analysis of telomere lengths in cloned sheep. Nature 399: 316-317
186. 186 Wynn R. F., Cross M. A., Hatton C., Will A. M., Lashford L. S., Dexter T. M. et al. (1998) Accelerated telomere shortening in young recipients of allogeneic bone-marrow transplants. Lancet 351: 178-181
187. 187 Akiyama M., Hoshi Y., Sakurai S., Yamada H., Yamada O. and Mizoguchi H. (1998) Changes of telomere length in children after hematopoietic stem cell transplantation. Bone Marrow Transplant. 21: 167-171
188. 188 Frenck R. W. Jr, Blackburn E. H. and Shannon K. M. (1998) The rate of telomere sequence loss in human leukocytes varies with age. Proc. Natl. Acad. Sci. USA 95: 5607-5610
189. 189 Zeichner S. L., Palumbo P., Feng Y., Xiao X., Gee D., Sleasman J. et al. (1999) Rapid telomere shortening in children. Blood 93: 2824-2830
190. 190 Hornsby P. J. (1999) The new science and medicine of cell transplantation. ASM News 65: 208-214
191. 191 Ferber D. (1999) Lab-grown organs begin to take shape. Science 284: 422-425
192. 192 Faragher R. G., Jones C. J. and Kipling D. (1998) Telomerase and cellular lifespan: ending the debate? Nature Biotech. 16: 701-702
193. 193 Rubin H. (1999) Resolving contradictory reports on cell aging. Nature Biotech. 17: 4
194. 194 Kipling D. and Faragher R. G. (1999) Telomeres. Ageing hard or hardly ageing? Nature 398: 191-193
195. 195 Kipling D., Wynford-Thomas D., Jones C. J., Akbar A., Aspinall R., Bacchetti S. et al. (1999) Telomere-dependent senescence. Nature Biotech. 17: 313-314
196. 196 Hsin H. and Kenyon C. (1999) Signals from the reproductive system regulate the lifespan of C. elegans. Nature 399: 362-366
197. 197 Greenberg R. A., O'Hagan R. C., Deng H., Xiao Q., Hann S. R., Adams R. R. et al. (1999) Telomerase reverse transcriptase gene is a direct target of c-Myc but is not functionally equivalent in cellular transformation. Oncogene 18: 1219-1226
198. 198 Wu K. J., Grandori C., Amacker M., Simon-Vermot N., Polack A., Lingner J. et al. (1999) Direct activation of TERT transcription by c-Myc. Nature Genet. 21: 220-224
199. 199 Pelengaris S., Littlewood T., Khan M., Elia G. and Evan G. (1999) Reversible activation of c-Myc in skin: induction of a complex neoplastic phenotype by a single oncogenic lesion. Mol. Cell 3: 565-577
200. 200 Norrback K. F. and Roos G. (1997) Telomeres and telomerase in normal and malignant haematopoietic cells. Eur. J. Cancer 33: 774-780
201. 201 Nugent C. I., Bosco G., Ross L. O., Evans S. K., Salinger A. P., Moore J. K. et al. (1998) Telomere maintenance is dependent on activities required for end repair of double-strand breaks. Curr. Biol. 8: 657-660
202. 202 Takahashi H. and Fujiwara H. (1999) Transcription analysis of the telomeric repeat-specific retrotransposons TRAS1 and SART1 of the silkworm Bombyx mori. Nucleic Acids Res. 27: 2015-2021
203. 203 Reference removed in proof
204. 204 Gandhi L. and Collins K. (1998) Interaction of recombinant Tetrahymena telomerase proteins p80 and p95 with telomerase RNA and telomeric DNA substrates. Genes Dev. 12: 721-733
205. 205 Hammond P. W., Lively T. N. and Cech T. R. (1997) The anchor site of telomerase from Euplotes aediculatus revealed by photo-cross-linking to single-and double-stranded DNA primers. Mol. Cell. Biol. 17: 296-308
206. 206 McClintock B. (1941) The stability of broken ends of chromosomes in Zea mays. Genetics 26: 234-282
207. 207 Moyzis R. K., Buckingham J. M., Cram L. S., Dani M., Deaven L. L., Jones M. D. et al. (1988) A highly conserved repetitive DNA sequence (TTAGGG)n, present at the telomeres of human chromosomes. Proc. Natl. Acad. Sci. USA 85: 6622-6626
208. 208 Yu G. L., Bradley J. D., Attardi L. D. and Blackburn E. H. (1990) In vivo alteration of telomere sequences and senescence caused by mutated Tetrahymena-telomerase RNAs. Nature 344: 126-132
209. 209 Allsopp R. C., Vaziri H., Patterson C., Goldstein S., Younglai E. V., Futcher A. B. et al. (1992) Telomere length predicts replicative capacity of human fibroblasts. Proc. Natl. Acad. Sci. USA 89: 10114-10118
210. 210 Vaziri H., Schachter F., Uchida I., Wei L., Zhu X., Effros R. et al. (1993) Loss of telomeric DNA during aging of normal and trisomy 21 human lymphocytes. Am. J. Hum. Genet. 52: 661-667
211. 211 Vaziri H., Dragowska W., Allsopp R. C., Thomas T. E., Harley C. B. and Lansdorp P. M. (1994) Evidence for a mitotic clock in human hematopoietic stem cells: loss of telomeric DNA with age. Proc. Natl. Acad. Sci. USA 91: 9857-9860
212. 212 Nilsson P., Mehle C., Remes K. and Roos G. (1994) Telomerase activity in vivo in human malignant hematopoietic cells. Oncogene 9: 3043-3048
213. 213 Chong L., Steensel B. v, Broccoli D., Erdjument-Bromage H., Hanish J., Tempst P. et al. (1995) A human telomeric protein. Science 270: 1663-1667
214. 214 Counter C. M., Meyerson M., Eaton E. N., Ellisen L. W., Caddle S. D., Haber D. A. et al. (1998) Telomerase activity is restored in human cells by ectopic expression of hTERT (hEST2), the catalytic subunit of telomerase. Oncogene 16: 1217-1222
215. 215 Nakayama J., Tahara H., Tahara E., Saito M., Ito K., Nakamura H. et al. (1998) Telomerase activation by hTRT in human normal fibroblasts and hepatocellular carcinomas. Nature Genet. 18: 65-68
216. 216 Vaziri H. and Benchimol S. (1998) Reconstitution of telomerase activity in normal human cells leads to elongation of telomeres and extended replicative life span. Curr. Biol. 8: 279-282
217. 217 Cong Y. S., Wen J. and Bacchetti S. (1999) The human telomerase catalytic subunit hTERT: organization of the gene and characterization of the promoter. Hum. Mol. Genet. 8: 137-142
218. 218 Wick M., Zubov D. and Hagen G. (1999) Genomic organization and promoter characterization of the gene encoding the human telomerase reverse transcriptase (hTERT). Gene 232: 97-106
219. 219 Horikawa I., Cable P. E., Afshari C. and Barrett J. C. (1999) Cloning and characterization of the promoter region of human telomerase reverse transcriptase gene. Cancer Res. 59: 826-830
220. 220 Takakura M., Kyo S., Kanaya T., Hirano H., Takeda J., Yutsudo M. et al. (1999) Cloning of human telomerase catalytic subunit (hTERT) gene promoter and identification of proximal core promoter sequences essential for transcriptional activation in immortalized and cancer cells. Cancer Res. 59: 551-557
221. 221 Chin L., Artandi S. E., Shen Q., Tam A., Lee S. E., Gottlieb G. J. et al. (1999) p53 deficiency rescues the adverse effects of telomere loss and cooperates with telomere dysfunction to accelerate carcinogenesis. Cell 97: 527-538
222. 222 Shippen-Lentz D. and Blackburn E. H. (1989) Telomere terminal transferase activity from Euplotes crassus adds large numbers of TTTTGGGG repeats onto telomeric primers. Mol. Cell. Biol. 9: 2761-2764
223. 223 Singer M. S. and Gottschling D. E. (1994) TLC1: template RNA component of Saccharomyces cerevisiae telomerase. Science 266: 404-409
224. 224 McEachern M. J. and Blackburn E. H. (1994) A conserved sequence motif within the exceptionally diverse telomeric sequences of budding yeasts. Proc. Natl. Acad. Sci. USA 91: 3453-3457
225. 225 Fulton T. B. and Blackburn E. H. (1998) Identification of Kluyveromyces lactis telomerase: discontinuous synthesis along the 30-nucleotide-long templating domain. Mol. Cell. Biol. 18: 4961-4970
226. 226 Blackburn E. H. and Challoner P. B. (1984) Identification of a telomeric DNA sequence in Trypanosoma brucei. Cell 36: 447-457
227. 227 Freitas-Junior L. H., Porto R. M., Pirrit L. A., Schenkman S. and Scherf A. (1999) Identification of the telomere in Trypanosoma cruzi reveals highly heterogeneous telomere lengths in different parasite strains. Nucleic Acids Res. 27: 2451-2456
228. 228 Cano M. I., Dungan J. M., Agabian N. and Blackburn E. H. (1999) Telomerase in kinetoplastid parasitic protozoa. Proc. Natl. Acad. Sci. USA 96: 3616-3621
229. 229 Petracek M. E., Lefebvre P. A., Silflow C. D. and Berman J. (1990) Chlamydomonas telomere sequences are A + T-rich but contain three consecutive G-C base pairs. Proc. Natl. Acaci. Sci. USA 87: 8222-8226
230. 230 Forney J., Henderson E. R. and Blackburn E. H. (1987) Identification of the telomeric sequence of the acellular slime molds Didymium iridis and Physarum polycephalum. Nucleic Acids Res. 15: 9143-9152
231. 231 Shimada Y., Nakano M., Kanda N., Murakami-Murofushi K., Kim J. K., Ide T. et al. (1997) Cell cycle-dependent activation of telomerase in naturally synchronized culture of a true slime mold, Physarum polycephalum. Biochem. Biophys. Res. Commun. 232: 492-496
232. 232 Emery H. S. and Weiner A. M. (1981) An irregular satellite sequence is found at the termini of the linear extrachromosomal rDNA in Dictyostelium discoideum. Cell 26: 411-419
233. 233 Koziol C, Borojevic R., Steffen R. and Müller W. E. G. (1998) Sponges (Porifera) model systems to study the shift from immortal to senescent somatic cells: the telomerase activity in somatic cells. Mechanisms Ageing Dev. 100: 107-120
234. 234 Burr B., Burr F. A., Matz E. C. and Romero-Severson J. (1992) Pinning down loose ends: mapping telomeres and factors affecting their length. Plant Cell 4: 953-960
235. 235 Kipling D. and Cooke H. J. (1990) Hypervariable ultra-long telomeres in mice. Nature 347: 400-402
236. 236 Starling J. A., Maule J., Hastie N. D. and Allshire R. C. (1990) Extensive telomere repeat arrays in mouse are hypervariable. Nucleic Acids Res. 18: 6881-6888
237. 237 Lejnine S., Makarov V. and Langmore J. P. (1995) Conserved nucleoprotein structure at the ends of vertebrate and invertebrate chromosomes. Proc. Natl. Acad. Sci. USA 92: 2393-2397
238. 238 Lingner J., Hendrick L. L. and Cech T. R. (1994) Telomerase RNAs of different ciliates have a common secondary structure and a permuted template. Genes Dev. 8: 1984-1998
239. 239 McEaehern M. J. and Blackburn E. H. (1995) Runaway telomere elongation caused by telomerase RNA gene mutations. Nature 376: 403-409
240. 240 Bottius E., Bakhsis N. and Scherf A. (1998) Plasmodium falciparum telomerase: de novo telomere addition to telomeric and nonteomeric sequences and role in chromosome healing. Mol. Cell. Biol. 18: 919-925
241. 241 Horikawa I., Oshimura M. and Barrett J. C. (1998) Repression of the telomerase catalytic subunit by a gene on human chromosome 3 that induces cellular senescence. Mol. Carcinog. 22: 65-72
242. 242 Tanaka H., Shimizu M., Horikawa I., Kugoh H., Yokota J., Barrett J. C. et al. (1998) Evidence for a putative telomerase repressor gene in the 3p14.2-p21.1 region. Genes Chromosomes Cancer 23: 123-133
243. 243 Cuthbert A. P., Bond J., Trott D. A., Gill S., Broni J., Marriott A. et al. (1999) Telomerase repressor sequences on chromosome 3 and induction of permanent growth arrest in human breast cancer cells. J. Natl. Cancer Inst. 91: 37-45
244. 244 Holt S. E., Aisner D. L., Baur J., Tesmer V. M., Dy M., Ouellette M. et al. (1999) Functional requirement of p23 and hsp90 in telomerase complexes. Genes Dev. 13: 817-826
245. 245 Bryan T. M., Englezou A., Dalla-Pozza L., Dunham M. A. and Reddel R. R. (1997) Evidence for an alternative mechanism for maintaining telomere length in human tumors and tumor-derived cell lines. Nature Med. 3: 1271-1274
246. 246 de Lange T. and Jacks T. (1999) For better or worse? Telomerase inhibition and cancer. Cell 98: 273-275
247. 247 Rudolph K. L., Chang S., Lee H. W., Blasco M., Gottlieb G. J., Greider C. et al. (1999) Longevity, stress response and cancer in aging telomerase-deficient mice. Cell 96: 701-712
248. 248 Hahn W. C., Counter C. M., Lundberg A. S., Beijersbergen R. L., Brooks M. W. and Weinberg R. A. (1999) Creation of human tumour cells with defined genetic elements. Nature 400: 464-468